Canada markets closed

NLS Pharmaceutics AG (NLSP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.8300+0.0600 (+3.39%)
At close: 1:00PM EST
1.8300 0.00 (0.00%)
After hours: 04:58PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 523.73M
Enterprise Value 325.72M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.59
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7-4.27

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-36.68%
S&P500 52-Week Change 326.87%
52 Week High 37.3500
52 Week Low 31.7100
50-Day Moving Average 32.2950
200-Day Moving Average 32.9452

Share Statistics

Avg Vol (3 month) 364.77k
Avg Vol (10 day) 394.81k
Shares Outstanding 513.41M
Implied Shares Outstanding 6N/A
Float 86.03M
% Held by Insiders 145.57%
% Held by Institutions 112.22%
Shares Short (Nov. 14, 2021) 479.8k
Short Ratio (Nov. 14, 2021) 41.53
Short % of Float (Nov. 14, 2021) 41.40%
Short % of Shares Outstanding (Nov. 14, 2021) 40.60%
Shares Short (prior month Oct. 14, 2021) 461.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-80.82%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-6.23M
Diluted EPS (ttm)-0.6910
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.09M
Total Cash Per Share (mrq)0.59
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.91
Book Value Per Share (mrq)0.35

Cash Flow Statement

Operating Cash Flow (ttm)-9.93M
Levered Free Cash Flow (ttm)-7.49M